We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

157 hedge funds and large institutions have $646M invested in Collegium Pharmaceutical in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 52 increasing their positions, 68 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

219% more call options, than puts

Call options by funds: $628K | Put options by funds: $197K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.85% less ownership

Funds ownership: 108.09% → 107.24% (-0.85%)

9% less funds holding

Funds holding: 172 → 157 (-15)

12% less capital invested

Capital invested by funds: $734M → $646M (-$88.4M)

24% less repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 68

32% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 25

Holders
157
Holders Change
-15
Holders Change %
-8.72%
% of All Funds
2.64%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
52
Reduced
68
Closed
25
Calls
$628K
Puts
$197K
Net Calls
+$431K
Net Calls Change
+$209K

Top Buyers

Rank Fund Capital Flow
1
Principal Financial Group
Principal Financial Group
Iowa
+$5.4M
2
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Illinois
+$5.37M
3
RCMNY
Rubric Capital Management (New York)
New York
+$4.35M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$4.04M
5
RA
Royce & Associates
New York
+$2.84M

Top Sellers

Rank Fund Capital Flow
1
Pacer Advisors
Pacer Advisors
Pennsylvania
-$4.5M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$4.41M
3
RHJA
Rice Hall James & Associates
California
-$2.7M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$2.49M
5
DZ Bank
DZ Bank
Germany
-$2.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$4.68M -$444K -26,389 -9%
JP Morgan Chase
27
JP Morgan Chase
New York
$4.58M +$2.3M +136,736 +112%
SDIC
28
South Dakota Investment Council
South Dakota
$4.49M +$580K +34,482 +16%
N
29
Nuveen
North Carolina
$4.47M +$36.2K +2,149 +0.9%
Charles Schwab
30
Charles Schwab
California
$4.3M -$143K -8,509 -3%
Adage Capital Partners
31
Adage Capital Partners
Massachusetts
$4.25M +$4.04M +240,000 New
LPL Financial
32
LPL Financial
California
$2.96M -$1.82K -108 -0.1%
Citadel Advisors
33
Citadel Advisors
Florida
$2.91M +$972K +57,782 +54%
MPAM
34
Monarch Partners Asset Management
Massachusetts
$2.75M +$1.27M +75,226 +94%
CC
35
Clearline Capital
New York
$2.71M +$2.58M +153,094 New
SEI Investments
36
SEI Investments
Pennsylvania
$2.54M -$189K -11,207 -7%
DZ Bank
37
DZ Bank
Germany
$2.49M -$2.16M -128,619 -48%
Victory Capital Management
38
Victory Capital Management
Texas
$2.35M +$390K +23,169 +21%
JIC
39
Johnson Investment Counsel
Ohio
$2.23M -$28.8K -1,712 -1%
Los Angeles Capital Management
40
Los Angeles Capital Management
California
$2.18M +$393K +23,379 +23%
ACM
41
Altium Capital Management
New York
$2.06M +$1.95M +116,000 New
SGI
42
Summit Global Investments
Utah
$1.96M +$947K +56,306 +104%
NM
43
Newtyn Management
New York
$1.86M +$1.77M +105,000 New
TA
44
Tamarack Advisers
California
$1.77M +$1.68M +100,000 New
Russell Investments Group
45
Russell Investments Group
United Kingdom
$1.74M -$175K -10,427 -10%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$1.65M -$48.2K -2,867 -3%
Legal & General Group
47
Legal & General Group
United Kingdom
$1.42M -$14.1K -836 -1%
Swiss National Bank
48
Swiss National Bank
Switzerland
$1.37M +$63.9K +3,800 +5%
ETC
49
Exchange Traded Concepts
Oklahoma
$1.35M +$38.3K +2,278 +3%
AQR Capital Management
50
AQR Capital Management
Connecticut
$1.33M +$686K +40,806 +119%
1
2
3 4 5

COLL Hedge Fund Activity: Q2 2022 in Review

157 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q2 2022, worth a combined $646M — down 12% from $734M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of COLL and 17 opened new positions — a net loss of 8 holders — while 68 trimmed existing stakes and 52 added.

The largest buyer was Principal Financial Group, adding an estimated $5.4M. The largest seller was Pacer Advisors, exiting entirely with an estimated $4.5M sold.

  • 157 institutional investors held Collegium Pharmaceutical (COLL) as of Q2 2022, down from 172 in Q1 2022.
  • Funds reported $646M of Collegium Pharmaceutical stock for Q2 2022, down 12% quarter-over-quarter.
  • 17 funds opened new Collegium Pharmaceutical positions in Q2 2022 and 25 closed out, a net change of -8 holders.
  • The largest Collegium Pharmaceutical buyer in Q2 2022 was Principal Financial Group, an estimated $5.4M added.
  • The largest Collegium Pharmaceutical seller in Q2 2022 was Pacer Advisors, an estimated $4.5M sold.

Based on aggregated 13F filings for Q2 2022.